Guardant Health Inc. News
5 Headwinds Facing Liquid Biopsies in Colon Cancer Screening
Exact Sciences, maker of Cologuard, won't be dethroned anytime soon.
Cathie Wood Watch: Ark Reverses Course, Buys Shopify
Cathie Wood, CEO of Ark Investment Management, reversed her stance on two major technology companies.
Cramer's Mad Money Recap 1/6: Constellation Brands, Bed Bath & Beyond
Jim Cramer says we haven't seen the signs that mark the bottom of this downtrend, so be prepared for more losses and for selective buying opportunities.
Twist Bioscience Drops Most in 10 Months After JPMorgan Downgrade
Twist Biosciences was downgraded on valuation concerns at JPMorgan despite topping Wall Street consensus estimates.
Stuck on Stimulus: Cramer's 'Mad Money' Recap (Friday 10/9/20)
Jim Cramer says investors need to stick with stocks that don't need government stimulus. And, he's got your game plan for next week.
Big Victory for the Bulls: Cramer's 'Mad Money' Recap
Jim Cramer says that in the heart of earnings season, Wall Street analysts can make important calls that let bulls push stocks higher.
Berkshire Hathaway, Seattle Genetics, Zynerba: 'Mad Money' Lightning Round
Jim Cramer takes a look at Berkshire Hathaway, Seattle Genetics, Zynerba Pharmaceuticals, Range Resources, Guardant Health, Danaher and more.
Fed Inflation Gauge Slowed Again in October, Supporting Dovish Powell
Further slowing in the Fed's preferred inflation gauge is adding heft to Chairman Jerome Powell's signals of smaller rate hikes.
Amazon Needs to Kill Alexa, Maybe Exit Echo Devices
The online retail giant had a plan to own your living room. It didn't work because AI-powered voice assistants don't work.
Amazon VP: Watch Out For These Common Holiday Scams
Online scams are more widespread than ever. Here's how to avoid them.